Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208689 · ClinicalTrials.gov registry record
Critical Congenital Heart Defect (CHD) Outcomes in Children
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 150
- Enrollment target
NCT00208689 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 150 participants.
The verdict
NCT00208689 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Congenital heart disease in infants and children often challenges healthcare providers both in regards to diagnosis and in the management of these conditions. The field becomes more complicated as one examines the myriad of defects that present and the complex care that is required. Over the last 20-25 years, the remarkable advances in the medical and surgical management of the most complex lesions have decreased neonatal mortality, such that many more survive the neonatal period. Therefore, new challenges regarding the continued care of this patient cohort of high-risk infants and children exist. In order to continue the improvement of treatment(s) offered to these patients, continuous review and analysis of the current standard of care is needed. In this study, the investigators will collect information related to the current surgical and medical therapies offered to patients enrolled in the High Risk Congenital Heart Program at Children's Healthcare of Atlanta. All of the procedure and visit information will be a part of the child's standard of care. This information will be placed in a database. The investigators hope to learn more about the short-term and long-term effects of current therapies and procedures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2004-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208689
The ClinicalTrials.gov registry entry for NCT00208689 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00208689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208689 about?
NCT00208689 is a clinical study titled "Critical Congenital Heart Defect (CHD) Outcomes in Children". Congenital heart disease in infants and children often challenges healthcare providers both in regards to diagnosis and in the management of these conditions. The field becomes more complicated as one examines the myriad of defects that present and the complex care that is required. Over the last 20...
What is the current status of trial NCT00208689?
This trial is currently terminated. The enrollment target is 150 participants. The study started on 2004-01.
Who is sponsoring clinical trial NCT00208689?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.